logo
logo

Visby Medical Tests Positive For A Series E Extension At $1B+ Valuation

Jul 01, 2022about 3 years ago

Round Type

series e

Description

Medical diagnostics company Visby Medical raised $100 million in a Series E round earlier this year. Today, the company told me it extended that round by an additional $35 million at the same valuation as the rest of the round. This financing will enable Visby Medical to scale production capacity from tens to hundreds of thousands of monthly tests. It will also further expand its product lineup to include COVID + influenza A/B combination testing, antimicrobial resistance panels, and deliver at-home PCR diagnostics to consumers.

Company Information

Company

Visby Medical

About

Visby Medical is a molecular diagnostics company driven by the belief that anyone should be able to test for any infection, anywhere, with near 100% accuracy.

FundzWatch™ Score

81
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood